BiotechTube

Alteplase "push" protocol + alteplase dwell arm

ApprovedTerminated
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Thrombosis

Conditions

Thrombosis

Trial Timeline

Sep 1, 2004 → Dec 1, 2008

NCT ID
NCT00303420

About Alteplase "push" protocol + alteplase dwell arm

Alteplase "push" protocol + alteplase dwell arm is a approved stage product being developed by Roche for Thrombosis. The current trial status is terminated. This product is registered under clinical trial identifier NCT00303420. Target conditions include Thrombosis.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00303420ApprovedTerminated

Competing Products

20 competing products in Thrombosis

See all competitors
ProductCompanyStageHype Score
CS1-Sodium ValproateCereno ScientificPhase 1
28
Edoxaban low dose + Edoxaban high doseDaiichi SankyoPhase 1
33
DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitorDaiichi SankyoPhase 2
52
edoxaban tosylate + enoxaparin/unfractionated heparin + warfarinDaiichi SankyoPhase 2
52
Rivaroxaban (Xarelto, BAY59-7939)Johnson & JohnsonPhase 2
52
Warfarin (Coumadin) + Rivaroxaban (Xarelto, BAY59-7939) + Placebo + Vitamin K (Konakion)Johnson & JohnsonPhase 1
33
Rivaroxaban (Xarelto, BAY59-7939) + Enoxaparin followed by VKAJohnson & JohnsonPhase 3
77
SHR2285 tablet + PlaceboJiangsu Hengrui MedicinePhase 1
33
SHR2285 + PlaceboJiangsu Hengrui MedicinePhase 1
33
Aspirin、clopidogrel、placebo or SHR2285 + Aspirin、clopidogrel、placebo or SHR2285 + Aspirin、ticagrelor、placebo or SHR2285Jiangsu Hengrui MedicinePhase 1
33
Rosuvastatin (AZD4522) + PlaceboAstraZenecaPhase 3
77
MK-2060 + PlaceboMerckPhase 1
33
dabigatran etexilate + rivaroxabanMerckPhase 1
33
Apixaban IR + Apixaban MR1 + Apixaban MR2 + Apixaban MR3PfizerPhase 1
32
Enoxaparin + warfarin + Placebo for apixaban + Placebo for enoxaparin + Placebo for warfarin + apixabanPfizerPhase 3
76
Apixaban + PlaceboPfizerPhase 3
76
90ug levonorgestrel / 20 ug ethinyl estradiol + Oral Contraceptives containing 20 ug of ethinyl estradiolPfizerPre-clinical
22
Fragmin (dalteparin sodium )PfizerPre-clinical
22
PD 0348292 + EnoxaparinPfizerPhase 2
51
Dalteparin + WarfarinPfizerPhase 2
51

Other Products from Roche

EmicizumabApproved
85
rituximab + methotrexate + methylprednisolone + acetaminophen + antihistamineApproved
85
RituximabApproved
85
mycophenolate mofetil [CellCept]Approved
85
saquinavir/ritonavir + atazanavir/ritonavirApproved
85